Report Detail
Global Medical Cannabis Market Insights, Forecast to 2025
- RnM3536374 |
- 17 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market.
The global Medical Cannabis market is valued at 3520 million US$ in 2018 and will reach 20200 million US$ by the end of 2025, growing at a CAGR of 24.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Medical Cannabis market based on company, product type, end user and key regions.
This report studies the global market size of Medical Cannabis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Medical Cannabis in these regions.
This research report categorizes the global Medical Cannabis market by top players/brands, region, type and end user. This report also studies the global Medical Cannabis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Market size by Product
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Market size by End User
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Medical Cannabis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Medical Cannabis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Medical Cannabis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Medical Cannabis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Medical Cannabis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Medical Cannabis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Medical Cannabis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Medical Cannabis Market Size Growth Rate by Product
- 1.4.2 Tetrahydrocannabinol (THC)
- 1.4.3 Cannabidiol (CBD)
- 1.5 Market by End User
- 1.5.1 Global Medical Cannabis Market Size Growth Rate by End User
- 1.5.2 Pain
- 1.5.3 Arthritis
- 1.5.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Medical Cannabis Market Size
- 2.1.1 Global Medical Cannabis Revenue 2014-2025
- 2.1.2 Global Medical Cannabis Sales 2014-2025
- 2.2 Medical Cannabis Growth Rate by Regions
- 2.2.1 Global Medical Cannabis Sales by Regions
- 2.2.2 Global Medical Cannabis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Medical Cannabis Sales by Manufacturers
- 3.1.1 Medical Cannabis Sales by Manufacturers
- 3.1.2 Medical Cannabis Sales Market Share by Manufacturers
- 3.1.3 Global Medical Cannabis Market Concentration Ratio (CR5 and HHI)
- 3.2 Medical Cannabis Revenue by Manufacturers
- 3.2.1 Medical Cannabis Revenue by Manufacturers (2014-2019)
- 3.2.2 Medical Cannabis Revenue Share by Manufacturers (2014-2019)
- 3.3 Medical Cannabis Price by Manufacturers
- 3.4 Medical Cannabis Manufacturing Base Distribution, Product Types
- 3.4.1 Medical Cannabis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Medical Cannabis Product Type
- 3.4.3 Date of International Manufacturers Enter into Medical Cannabis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Medical Cannabis Sales by Product
- 4.2 Global Medical Cannabis Revenue by Product
- 4.3 Medical Cannabis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Medical Cannabis Breakdown Data by End User
6 North America
- 6.1 North America Medical Cannabis by Countries
- 6.1.1 North America Medical Cannabis Sales by Countries
- 6.1.2 North America Medical Cannabis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Medical Cannabis by Product
- 6.3 North America Medical Cannabis by End User
7 Europe
- 7.1 Europe Medical Cannabis by Countries
- 7.1.1 Europe Medical Cannabis Sales by Countries
- 7.1.2 Europe Medical Cannabis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Medical Cannabis by Product
- 7.3 Europe Medical Cannabis by End User
8 Asia Pacific
- 8.1 Asia Pacific Medical Cannabis by Countries
- 8.1.1 Asia Pacific Medical Cannabis Sales by Countries
- 8.1.2 Asia Pacific Medical Cannabis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Medical Cannabis by Product
- 8.3 Asia Pacific Medical Cannabis by End User
9 Central & South America
- 9.1 Central & South America Medical Cannabis by Countries
- 9.1.1 Central & South America Medical Cannabis Sales by Countries
- 9.1.2 Central & South America Medical Cannabis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Medical Cannabis by Product
- 9.3 Central & South America Medical Cannabis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Medical Cannabis by Countries
- 10.1.1 Middle East and Africa Medical Cannabis Sales by Countries
- 10.1.2 Middle East and Africa Medical Cannabis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Medical Cannabis by Product
- 10.3 Middle East and Africa Medical Cannabis by End User
11 Company Profiles
- 11.1 BOL Pharma
- 11.1.1 BOL Pharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 BOL Pharma Medical Cannabis Products Offered
- 11.1.5 BOL Pharma Recent Development
- 11.2 Tilray
- 11.2.1 Tilray Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Tilray Medical Cannabis Products Offered
- 11.2.5 Tilray Recent Development
- 11.3 Medreleaf Corporation
- 11.3.1 Medreleaf Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Medreleaf Corporation Medical Cannabis Products Offered
- 11.3.5 Medreleaf Corporation Recent Development
- 11.4 Aurora Cannabis, Inc
- 11.4.1 Aurora Cannabis, Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Aurora Cannabis, Inc Medical Cannabis Products Offered
- 11.4.5 Aurora Cannabis, Inc Recent Development
- 11.5 Canopy Growth Corporation
- 11.5.1 Canopy Growth Corporation Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Canopy Growth Corporation Medical Cannabis Products Offered
- 11.5.5 Canopy Growth Corporation Recent Development
- 11.6 Insys Therapeutics, Inc
- 11.6.1 Insys Therapeutics, Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Insys Therapeutics, Inc Medical Cannabis Products Offered
- 11.6.5 Insys Therapeutics, Inc Recent Development
- 11.7 Aphria, Inc
- 11.7.1 Aphria, Inc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Aphria, Inc Medical Cannabis Products Offered
- 11.7.5 Aphria, Inc Recent Development
- 11.8 MGC Pharmaceuticals Limited
- 11.8.1 MGC Pharmaceuticals Limited Company Details
- 11.8.2 Company Business Overview
- 11.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 MGC Pharmaceuticals Limited Medical Cannabis Products Offered
- 11.8.5 MGC Pharmaceuticals Limited Recent Development
- 11.9 GW Pharmaceuticals, plc
- 11.9.1 GW Pharmaceuticals, plc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GW Pharmaceuticals, plc Medical Cannabis Products Offered
- 11.9.5 GW Pharmaceuticals, plc Recent Development
- 11.10 Medical Marijuana Inc
- 11.10.1 Medical Marijuana Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Medical Marijuana Inc Medical Cannabis Products Offered
- 11.10.5 Medical Marijuana Inc Recent Development
12 Future Forecast
- 12.1 Medical Cannabis Market Forecast by Regions
- 12.1.1 Global Medical Cannabis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Medical Cannabis Revenue Forecast by Regions 2019-2025
- 12.2 Medical Cannabis Market Forecast by Product
- 12.2.1 Global Medical Cannabis Sales Forecast by Product 2019-2025
- 12.2.2 Global Medical Cannabis Revenue Forecast by Product 2019-2025
- 12.3 Medical Cannabis Market Forecast by End User
- 12.4 North America Medical Cannabis Forecast
- 12.5 Europe Medical Cannabis Forecast
- 12.6 Asia Pacific Medical Cannabis Forecast
- 12.7 Central & South America Medical Cannabis Forecast
- 12.8 Middle East and Africa Medical Cannabis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Medical Cannabis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Medical Cannabis . Industry analysis & Market Report on Medical Cannabis is a syndicated market report, published as Global Medical Cannabis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Medical Cannabis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
